Peripheral endothelialization progression on fluoropolymer-coated left atrial appendage closure devices: Does device position influence healing?

The extent of endothelialization of left atrial appendage closure (LAAC) devices is a key determinant of thrombotic risk, particularly device-related thrombus (DRT) formation. Although animal models suggest that fluoropolymer (FP)-coated devices accelerate endothelial coverage and reduce thrombogenicity, clinical evidence remains limited. In particular, human data directly characterizing the extent, timing, and pattern of coverage are sparse, leaving the clinical relevance of FP-related acceleration unresolved.

Authors

Publication Details

Journal
HeartRhythm Case Reports
Published
2025-11-01
DOI
https://doi.org/10.1016/j.hrcr.2025.11.005
Primary Topic
Atrial Fibrillation Management and Outcomes
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Peripheral endothelialization progression on fluoropolymer-coated left atrial appendage closure devices: Does device position influence healing?

Hiroaki Watabe, Hiro Yamasaki, Kojiro Ogawa, Tomoko Machino‐Ohtsuka et al.
HeartRhythm Case Reports
Atrial Fibrillation Management and Outcomes
article

Peripheral endothelialization progression on fluoropolymer-coated left atrial appendage closure devices: Does device position influence healing?

Hiroaki Watabe, Hiro Yamasaki, Kojiro Ogawa, Tomoko Machino‐Ohtsuka, Kentaro Minami, Tomoko Ishizu
article en

Abstract

The extent of endothelialization of left atrial appendage closure (LAAC) devices is a key determinant of thrombotic risk, particularly device-related thrombus (DRT) formation. Although animal models suggest that fluoropolymer (FP)-coated devices accelerate endothelial coverage and reduce thrombogenicity, clinical evidence remains limited. In particular, human data directly characterizing the extent, timing, and pattern of coverage are sparse, leaving the clinical relevance of FP-related acceleration unresolved.

HeartRhythm Case Reports
Boston Scientific Corporation, Boston Scientific Japan
Openalex Percentile: Top 48%
Atrial Fibrillation Management and Outcomes
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.